Cargando…
Relevance of Human Papillomaviruses in Head and Neck Cancer—What Remains in 2021 from a Clinician’s Point of View?
Human papillomaviruses (HPV) cause a subset of head and neck cancers (HNSCC). HPV16 predominantly signs responsible for approximately 10% of all HNSCC and over 50% of tonsillar (T)SCCs. Prevalence rates depend on several factors, such as the geographical region where patients live, possibly due to d...
Autores principales: | Hoffmann, Markus, Quabius, Elgar Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235461/ https://www.ncbi.nlm.nih.gov/pubmed/34207440 http://dx.doi.org/10.3390/v13061173 |
Ejemplares similares
-
Human papillomavirus infection in head and neck cancer: The role of the secretory leukocyte protease inhibitor
por: HOFFMANN, MARKUS, et al.
Publicado: (2013) -
Head and neck cancer cells and xenografts are very sensitive to palytoxin: decrease of c-jun n-terminale kinase-3 expression enhances palytoxin toxicity
por: Görögh, Tibor, et al.
Publicado: (2013) -
The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Fazel, Asita, et al.
Publicado: (2020) -
Sequential activation of the AKT pathway in human osteoblasts treated with Oscarvit: a bioactive product with positive effect both on skeletal pain and mineralization in osteoblasts
por: Görögh, Tibor, et al.
Publicado: (2017) -
Myeloid Sarcoma: The Clinician's Point of View
por: Malagola, M., et al.
Publicado: (2011)